In Japan alone, more than 350,000 people die from solid tumor cancers each year.
To address the growing cancer burden in Asia, the Middle East, and Africa, we formed Guardant Health AMEA Inc., a joint venture with Softbank.
Europe and Americas
Guardant Health currently markets its tests in more than 40 countries outside the United States, primarily through distributor relationships or direct contracts with hospitals. All customer samples are shipped globally to the laboratory in Redwood City, California.